C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/1997
12/11/1997	WO1997046589A2 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods
12/11/1997	WO1997046585A2 Fragments of leptin (ob protein)
12/11/1997	WO1997046583A1 Novel feline cytokine protein
12/11/1997	WO1997046581A1 Viral peptides with structural homology to protein g of respiratory syncytial virus
12/11/1997	WO1997046580A1 Antibiotic producing microbe
12/11/1997	WO1997046259A2 Chimeric toxin for targeted therapy
12/11/1997	WO1997041443A3 Method for screening compounds
12/11/1997	WO1997041252A3 Dna, rna and a protein useful for detection of a mycobacterial infection
12/11/1997	CA2257943A1 Viral peptides with structural homology to protein g of respiratory syncytial virus
12/11/1997	CA2257240A1 Fragments of leptin (ob protein)
12/11/1997	CA2256522A1 Polynucleotides encoding secreted proteins
12/11/1997	CA2256464A1 Tumor necrosis factor-related polypeptide
12/11/1997	CA2254862A1 Metabotropic gaba[b] receptors, receptor-specific ligands and their uses
12/11/1997	CA2228618A1 Novel feline cytokine protein
12/10/1997	EP0811696A2 Method to obtain nucleotide sequence using randomly primed amplification
12/10/1997	EP0811691A1 Antibody againts alpha-chain of human interleukin 5 receptor
12/10/1997	EP0811688A2 Staphylococcus aureus RNase P
12/10/1997	EP0811686A2 Human platelet-derived growth factor receptors
12/10/1997	EP0811685A2 Human platelet-derived growth factor receptors
12/10/1997	EP0811684A2 Oxytocin receptor portion or variant, and dna coding for the same
12/10/1997	EP0811160A1 Nf-kappa b activation regulatory protein, i-kappa b-beta
12/10/1997	EP0811159A1 A process for identifiying pharmaceutically active agents using an epitope-tagged library
12/10/1997	EP0811078A1 Bcr-abl directed compositions and uses for inhibiting philadelphia chromosome stimulated cell growth
12/10/1997	EP0811076A1 ISOLATED NUCLEIC ACID MOLECULE ENCODING PEPTIDES WHICH FORM COMPLEXES WITH MHC MOLECULE HLA-Cw*1601 AND USES THEREOF
12/10/1997	EP0811071A1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins
12/10/1997	EP0811067A1 Equine arteritis virus peptides, antibodies and their use in a diagnostic test
12/10/1997	EP0811066A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
12/10/1997	EP0811065A1 Antagonists of interleukin-15
12/10/1997	EP0811064A2 Mpl ligand analogs
12/10/1997	EP0811063A2 Chemokine receptors 88-2b ckr-3] and 88c and their antibodies
12/10/1997	EP0811060A1 EUKARYOTIC INITIATION FACTOR 5A (eIF-5A) MUTANTS
12/10/1997	EP0811059A1 Human chemokine beta-11 and human chemokine alpha-1
12/10/1997	EP0811015A1 Immunoassay using antibodies directed to the reaction product of enzymes used as labels
12/10/1997	EP0811014A1 Novel bacteriocin piscicolin 126
12/10/1997	EP0811013A1 Isolated nonapeptides presented by hla molecules, and uses thereof
12/10/1997	EP0810874A1 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders
12/10/1997	EP0810870A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
12/10/1997	EP0610246B1 Novel thrombin-inhibiting protein from ticks
12/10/1997	CN1167505A Tie-2 ligands, methods of making and uses thereof
12/10/1997	CN1167440A Immunotherapeutic stress protein-peptide complexes against cancer
12/10/1997	CN1167155A Method for cleaving chimeric protein using processing enzyme
12/10/1997	CN1167150A Method for production of recombining human grunulocyte colony stimulation factor
12/10/1997	CN1167115A Anti-Fas recombinant antibodies and DNA therefor
12/09/1997	US5696237 Recombinant antibody-toxin fusion protein
12/09/1997	US5696091 Use of growth factor and antimetabolite combination to prevent or retard secondary cataract formation
12/09/1997	US5696088 Chimeric proteins
12/09/1997	US5696086 Administering before or after chemotherapy to promote thrombocyte production, also kits
12/09/1997	US5696076 5-lipoxygenase-activating protein II
12/09/1997	US5696000 Adhesion receptors for pathogenic or opportunistic microorganisms
12/09/1997	US5695994 Isolated cytolytic T cells specific for complexes of MAGE related peptides and HLA molecules
12/09/1997	US5695991 A complex between a virus the cell binding receptor of which has been inactivated and an antibody able to interact with specific antigen; antigen has ability to mediate entrance into mammalian cells
12/09/1997	US5695990 Phycobilisomes, derivatives, and uses therefor
12/09/1997	US5695961 Bi-functional expression system
12/09/1997	US5695960 Hippuricase gene
12/09/1997	US5695958 Aqueous multiple-phase isolation of polypeptide
12/09/1997	US5695953 DNA that encodes a tumor necrosis factor inhibitory protein and a recombinant method of production
12/09/1997	US5695950 Method of screening for antimitotic compounds using the cdc25 tyrosine phosphatase
12/09/1997	US5695945 Method of detecting DAF molecules in feces
12/09/1997	US5695939 Genetic engineered dna encoding chitinase protein
12/09/1997	US5695931 Nucleotide sequences coding for a protein with urease activity
12/09/1997	US5695928 Concurrent extraction, complexing
12/09/1997	US5695766 Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
12/09/1997	US5695760 Modified anti-ICAM-1 antibodies and their use in the treatment of inflammation
12/09/1997	US5695758 Hybridoma cells
12/09/1997	CA2135922C Quick-change tool holder with center-height adjustment mechanism
12/09/1997	CA2058935C Pharmaceutical compositions and method for treatment using alzheimer's amyloid peptides
12/04/1997	WO1997045538A1 Novel synthetic protein structural templates for the generation, screening and evolution of functional molecular surfaces
12/04/1997	WO1997045451A1 Anti-human lect2 antibody, cells producing the same, and method and kit for assaying the same
12/04/1997	WO1997045450A1 Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy
12/04/1997	WO1997045448A1 An interleukin-5 antagonist
12/04/1997	WO1997045136A1 Lactoferrin variants and uses thereof
12/04/1997	WO1997045128A1 Apoptosis associated protein bbk
12/04/1997	WO1997045106A1 Identification of genes altered in multiple myeloma
12/04/1997	WO1997040134A3 Human dnase ii
12/04/1997	WO1997037664A3 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
12/04/1997	CA2256455A1 Identification of genes altered in multiple myeloma
12/04/1997	CA2256453A1 Lactoferrin variants and uses thereof
12/04/1997	CA2256372A1 Apoptosis associated protein bbk
12/04/1997	CA2256368A1 An interleukin-5 antagonist
12/03/1997	EP0810285A2 Mutants of human Interleukin-3
12/03/1997	EP0810230A2 Anti-HIV antibodies used as control probes
12/03/1997	EP0809806A1 Monoclonal antibodies for human osteogenic cell surface antigens
12/03/1997	EP0809700A1 Papilloma virus-like particles, fusion proteins and process for producing the same
12/03/1997	EP0809699A1 New chemokines expressed in pancreas
12/03/1997	EP0809698A1 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF TUMOR GENE Int6
12/03/1997	EP0809696A1 Novel allele of human histamine h2 receptor and methods of detection of h2 receptor variants
12/03/1997	EP0809695A1 Transcription factor - e2f-5
12/03/1997	EP0809692A1 Materials and methods relating to the regulation of polypeptide production in cells
12/03/1997	EP0809656A1 MONOCLONAL ANTIBODY SPECIFIC FOR $g(b)A4 PEPTIDE
12/03/1997	EP0809649A1 HETEROLOGOUS POLYPEPTIDE PRODUCTION IN THE ABSENCE OF NONSENSE-MEDIATED mRNA DECAY FUNCTION
12/03/1997	EP0809648A1 Neuropeptide y receptor
12/03/1997	EP0809517A1 Anti-transforming growth factor-beta gene therapy
12/03/1997	EP0809510A1 LYMPHOTOXIN-$g(a)/$g(b) COMPLEXES AND ANTI-LYMPHOTOXIN-BETA RECEPTOR ANTIBODIES AS ANTI-TUMOR AGENTS
12/03/1997	EP0809490A1 Use of lck sh2 specific compounds to treat autoimmune diseases and allograft rejection
12/03/1997	EP0730651A4 Surface loop structural analogues of fibroblast growth factors
12/03/1997	EP0720618A4 Process for the purification of basic fibroblast growth factor
12/03/1997	EP0597852B1 Swine pneumonia vaccine and method for the preparation thereof
12/03/1997	CN1166857A New E. coli mutant with suppressed organic acid production
12/03/1997	CN1166838A Antibodies against allogenic and Xenogenic proteins, their use in diagnosis and therapy and methods for determination thereof
12/02/1997	US5693780 Recombinant antibodies for human therapy

1 ... 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 ... 1125